Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 06 04:00PM ET
3.00
Dollar change
0.00
Percentage change
0.00
%
Index- P/E- EPS (ttm)-0.42 Insider Own26.17% Shs Outstand70.05M Perf Week7.14%
Market Cap209.77M Forward P/E- EPS next Y-0.48 Insider Trans0.00% Shs Float51.62M Perf Month31.00%
Income-29.64M PEG- EPS next Q-0.12 Inst Own1.77% Short Float0.13% Perf Quarter33.93%
Sales0.00M P/S- EPS this Y-5.73% Inst Trans3.59% Short Ratio1.99 Perf Half Y22.95%
Book/sh0.99 P/B3.03 EPS next Y-7.00% ROA-30.02% Short Interest0.07M Perf Year-3.23%
Cash/sh0.98 P/C3.07 EPS next 5Y- ROE-37.22% 52W Range1.75 - 3.40 Perf YTD-0.33%
Dividend Est.- P/FCF- EPS past 5Y- ROI-36.62% 52W High-11.76% Beta0.86
Dividend TTM- Quick Ratio10.99 Sales past 5Y0.00% Gross Margin- 52W Low71.43% ATR (14)0.12
Dividend Ex-Date- Current Ratio10.99 EPS Y/Y TTM-16.78% Oper. Margin- RSI (14)78.97 Volatility3.70% 4.51%
Employees121 Debt/Eq0.18 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price8.75
Option/ShortNo / Yes LT Debt/Eq0.17 EPS Q/Q-39.89% Payout- Rel Volume1.91 Prev Close3.00
Sales Surprise- EPS Surprise16.87% Sales Q/Q- EarningsNov 19 AMC Avg Volume32.71K Price3.00
SMA2017.80% SMA5026.02% SMA20022.36% Trades Volume62,473 Change0.00%
Date Action Analyst Rating Change Price Target Change
Dec-15-23Initiated Citigroup Buy $8
Apr-24-23Initiated H.C. Wainwright Buy $9
Apr-14-22Initiated Cantor Fitzgerald Overweight $20
Apr-08-22Initiated Piper Sandler Overweight $19
Apr-04-22Initiated Citigroup Buy $21
Dec-06-24 08:30AM
08:30AM
Nov-19-24 04:00PM
Nov-13-24 08:30AM
Oct-21-24 08:30AM
08:57AM Loading…
Oct-11-24 08:57AM
Oct-10-24 08:30AM
Sep-20-24 08:30AM
Sep-17-24 08:00AM
Aug-22-24 08:30AM
Aug-14-24 04:02PM
Jun-25-24 08:30AM
May-21-24 08:45AM
May-20-24 09:53PM
04:01PM
08:30AM Loading…
May-13-24 08:30AM
May-06-24 08:30AM
May-01-24 08:30AM
Mar-25-24 08:50AM
Mar-07-24 10:53PM
04:01PM
Feb-26-24 08:30AM
Jan-22-24 09:40AM
Dec-20-23 09:15AM
Dec-05-23 10:25AM
Nov-29-23 08:30AM
Nov-28-23 08:30AM
Nov-20-23 08:30AM
Nov-16-23 04:30PM
Nov-01-23 08:30AM
07:00AM Loading…
07:00AM
Oct-31-23 07:00AM
Oct-30-23 08:30AM
Oct-24-23 09:00AM
Oct-04-23 07:00AM
Oct-03-23 07:00AM
Sep-14-23 08:30AM
Aug-28-23 04:02PM
Aug-24-23 08:00AM
Aug-17-23 05:00PM
Aug-08-23 07:00AM
Aug-06-23 08:28AM
Aug-02-23 09:00AM
Jun-13-23 08:00AM
May-24-23 04:01PM
May-23-23 04:01PM
May-17-23 04:30PM
May-11-23 04:00PM
May-03-23 04:00PM
Apr-03-23 09:10AM
Mar-29-23 04:00PM
Mar-12-23 08:30AM
Mar-09-23 04:10PM
Mar-08-23 05:00PM
Mar-03-23 08:30AM
Mar-01-23 08:30AM
Feb-21-23 04:00PM
Dec-13-22 08:00AM
Nov-22-22 04:02PM
Nov-09-22 08:00AM
Oct-21-22 04:01PM
Sep-08-22 04:05PM
Sep-01-22 04:15PM
Aug-30-22 04:05PM
Aug-25-22 04:05PM
Aug-22-22 09:00AM
Jul-05-22 04:01PM
Jun-22-22 04:01PM
Jun-16-22 04:01PM
Jun-08-22 09:10AM
Jun-07-22 04:03PM
May-26-22 04:05PM
May-23-22 09:00AM
Apr-12-22 10:39AM
Mar-28-22 08:00AM
Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.